Merck to cut 1,200 sales jobs

Share this article:
Merck announced plans to cut 1,200 sales jobs in the US. The layoffs follow an FDA rejection of Cordaptive, a cholesterol drug that was to be packaged with Zocor, and weak sales of Vytorin following the ENHANCE controversy.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions